Skip to Content

WPI 1.5 (Paliperidone Extended-Release 1.5 mg)

Pill with imprint WPI 1.5 is Beige, Round and has been identified as Paliperidone Extended-Release 1.5 mg. It is supplied by Actavis Pharma, Inc..

Paliperidone is used in the treatment of schizoaffective disorder; schizophrenia; bipolar disorder; borderline personality disorder; depression (and more), and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Paliperidone 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 1.5

Paliperidone Extended-Release

Imprint:
WPI 1.5
Strength:
1.5 mg
Color:
Beige
Shape:
Round
Availability:
Prescription only
Drug Class:
Atypical antipsychotics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Actavis Pharma, Inc.
National Drug Code (NDC):
00591-3692

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide